Byers T L, Lakanen J R, Coward J K, Pegg A E
Department of Cell and Molecular Physiology, M.S. Hershey Medical Center, Hershey, PA 17033.
Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):363-8. doi: 10.1042/bj3030363.
The abilities of the natural polyamines, spermidine and spermine, and of the synthetic analogues, 1-methylspermidine and 1,12-dimethylspermine, to reverse the effects of the S-adenosyl-L-methionine decarboxylase inhibitor 5'-([(Z)-4-aminobut-2-enyl]methylamino)-5'-deoxyadenosine (AbeAdo) on L1210-cell growth were studied. L1210 cells were exposed to AbeAdo for 12 days to induce cytostasis and then exposed to spermidine, spermine, 1-methylspermidine or 1,12-dimethylspermine in the continued presence of AbeAdo. AbeAdo-induced cytostasis was overcome by the natural polyamines, spermidine and spermine. The cytostasis was also reversed by 1-methylspermidine. 1,12-Dimethylspermine had no effect on the AbeAdo-induced cytostasis of chronically treated cells, although it was active in permitting growth of cells treated with the ornithine decarboxylase inhibitor, alpha-difluoromethylornithine. The initial 12-day exposure to AbeAdo elevated intracellular putrescine levels, depleted intracellular spermidine and spermine, and resulted in the accumulation of unmodified eukaryotic translation initiation factor 5A (eIF-5A). Exposure of these cells to exogenous spermidine, which is the natural substrate for deoxyhypusine synthase, resulted in a decrease in the unmodified eIF-5A content. 1-Methylspermidine, which was found to be a substrate of deoxyhypusine synthase in vitro, also decreased the levels of unmodified eIF-5A in the AbeAdo-treated cells. Although spermine is not a substrate of deoxyhypusine synthase, spermine was converted into spermidine in the L1210 cells, and spermine addition to AbeAdo-treated cells resulted in the appearance of both intracellular spermine and spermidine and in the decrease in unmodified eIF-5A. Exogenous 1,12-dimethylspermine, which was not metabolized to spermine or to 1-methylspermidine and was not a substrate of deoxyhypusine synthase in vitro, did not decrease levels of unmodified eIF-5A. The finding that AbeAdo-induced cytostasis was only reversed by polyamines and polyamine analogues that result in the formation of hypusine or an analogue in eIF-5A is consistent with the hypothesis [Byers, Wiest, Wechter and Pegg (1993) Biochem. J. 290, 115-121] that AbeAdo-induced cytostasis is due to the depletion of the hypusine-containing form of eIF-5A, which is secondary to the depletion of spermidine by inhibition of S-adenosyl-L-methionine decarboxylase.
研究了天然多胺亚精胺和精胺以及合成类似物1-甲基亚精胺和1,12-二甲基精胺逆转S-腺苷-L-甲硫氨酸脱羧酶抑制剂5'-([(Z)-4-氨基丁-2-烯基]甲基氨基)-5'-脱氧腺苷(AbeAdo)对L1210细胞生长影响的能力。将L1210细胞暴露于AbeAdo 12天以诱导细胞生长停滞,然后在持续存在AbeAdo的情况下暴露于亚精胺、精胺、1-甲基亚精胺或1,12-二甲基精胺。天然多胺亚精胺和精胺克服了AbeAdo诱导的细胞生长停滞。1-甲基亚精胺也逆转了细胞生长停滞。1,12-二甲基精胺对长期处理细胞的AbeAdo诱导的细胞生长停滞没有影响,尽管它在允许用鸟氨酸脱羧酶抑制剂α-二氟甲基鸟氨酸处理的细胞生长方面具有活性。最初12天暴露于AbeAdo会提高细胞内腐胺水平,耗尽细胞内亚精胺和精胺,并导致未修饰的真核翻译起始因子5A(eIF-5A)积累。将这些细胞暴露于作为脱氧hypusine合酶天然底物的外源性亚精胺会导致未修饰的eIF-5A含量降低。在体外被发现是脱氧hypusine合酶底物的1-甲基亚精胺也降低了AbeAdo处理细胞中未修饰的eIF-5A水平。尽管精胺不是脱氧hypusine合酶的底物,但精胺在L1210细胞中转化为亚精胺,向AbeAdo处理的细胞中添加精胺会导致细胞内亚精胺和精胺的出现以及未修饰的eIF-5A的减少。外源性1,12-二甲基精胺未代谢为精胺或1-甲基亚精胺,并且在体外不是脱氧hypusine合酶的底物,未降低未修饰的eIF-5A水平。AbeAdo诱导的细胞生长停滞仅被导致eIF-5A中hypusine或类似物形成的多胺和多胺类似物逆转这一发现与以下假设一致[拜尔斯、维斯特、韦克特和佩格(1993年)《生物化学杂志》290,115 - 121],即AbeAdo诱导的细胞生长停滞是由于eIF-5A含hypusine形式的耗尽,这是由于S-腺苷-L-甲硫氨酸脱羧酶的抑制导致亚精胺耗尽的继发结果。